AT BIOCONSCIOUS TECHNOLOGIES
Glucose is more than just a number - It's the 5th vital sign. It's the key in detecting, preventing, and managing chronic disease
THE DRIVING FORCE
GLUCOSE
Glucose beyond Diabetes
Understanding how glucose metabolism shapes diabetes management and long-term health.
Transforming Data into Action
Translate CGM data into actionable insights that improve patient care, streamline workflows, and enhance clinic revenue.
From Reaction to Protection
Investing in research to detect early patterns of Dysglycemia and prevent chronic conditions before they develop
OUR SCIENCE / OUR PRODUCT
Level 1 AI
Taking control of Diabetes starts with smarter insights
Level 2 AI
From data to decisions: AI-powered automated remote patient monitoring
OUR PRODUCT
Endobits
Endobits eliminates data overload by automating patient triage, highlighting risks, and providing AI-powered recommendations. With seamless integration into CGMs and EHRs, it lets clinicians prioritize care, not administrative processes.
Smarter insights. Faster decisions. Better outcomes. Endobits transforms CGM data into action—so you can prioritize patient care.
Curious about how Endobits can elevate your practice?
“The integration of CGM data with AI-powered solutions like Endobits represents a significant advancement in diabetes care, By utilizing these technologies, we can provide clinicians with actionable insights in real-time and make diabetes management more efficient and effective”
Dr Jerome Fischer
Chief Medical Officer & Renowned Endocrinologist
Level 3 AI
Decoding Dysglycemia: Predicting Chronic Diseases onset before it happens
01 Predict
We detect patterns of dysglycemia at the earliest asymptomatic stages of affliction.
02 Prioritize
AI-Driven classification helps prioritize patients by detecting early glucose abnormalities linked to metabolic disorders.
03 Prevent
By recognizing glucose as the 5th vital sign, we can help prevent metabolic diseases.
PARTNERSHIP: DEXCOM + ENDOBITS
Bioconscious Technologies is proud to announce a strategic API integration with Dexcom, a leader in continuous glucose monitoring (CGM) systems. This collaboration allows Endobits to seamlessly integrate Dexcom’s real-time glucose data, enhancing clinicians’ ability to deliver personalized care and empowering patients with actionable insights to manage their diabetes more effectively.
Explore our blog for the latest news in glucose monitoring, tips for managing diabetes, and updates on our technology.
Bio Conscious Announces Strategic API Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings
Jun 16, 2024
Blog
Bio Conscious Announces the Integration of GPT 4 LLM Into Its State-of-the-Art Endobits V5 - Creating a Unique Industry-Leading CGM Platform for Diabetes Care
Apr 25, 2024
Updates
AI-Powered Health Technology Company Bio Conscious Launches "Endobits V5" - An Industry-Leading Automated & Remote Patient Monitoring Platform To Revolutionize Diabetes Care
Mar 6, 2024
Updates
Bio-Conscious Announces Breakthrough in Forecasting Nocturnal Hypoglycemia Events Using Machine Learning (ML) Techniques and CGM data.
Aug 14, 2023
Blog
Bio-Conscious Announces Breakthrough in Forecasting High-Risk Diabetic Events Using Machine Learning (ML) Techniques and CGM data
Jun 22, 2023
Blog
GET IN TOUCH